Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Edwards Lifesciences Announces Appointment of CFO
-
Ares Capital Corporation Prices Public Offering of $800 Million 5.550% Unsecured Notes Due 2030
-
Ducommun Incorporated Appoints Mark A. Caylor to its Board of Directors
-
UFP Technologies Announces Strong Q1 Results
-
Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)
-
Atlas Energy Solutions Announces First Quarter 2026 Results
-
JBT Marel Corporation Reports First Quarter 2026 Results and Reiterates Full Year 2026 Guidance
-
Reuters wins Pulitzer Prizes for Beat Reporting and National Reporting; named finalist in Illustrated Reporting and Breaking News Photography
-
GRAND CANYON UNIVERSITY TO EXPAND ACCELERATED BACHELOR OF SCIENCE IN NURSING PROGRAM IN FLORIDA WITH NEW SITE IN MIRAMAR
-
Pan Global Resources Inc. to Present at Deutsche Goldmesse Spring 2026 in Frankfurt
-
Best Age to Start Dance Explained in HelloNation Featuring Dance Education Expert Jeanine Nielson
-
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
GoldQuest Reaffirms Commitment to Responsible Development of the Romero Project
-
Pool Corporation Announces Leadership Transition
-
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
-
Unitil Reports 2026 First Quarter Earnings
-
TC Transcontinental sells its Boucherville Warehouse to Carrousel
-
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
-
New Jersey Resources Reports Fiscal 2026 Second-Quarter Results
-
Improv Launches UKG EZCall Assessment to Help Organizations Unlock the Full Value of Their Call-Out Management Systems
-
BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
-
Campbell’s Completes Acquisition of 49% Interest in La Regina
-
MSA Safety Announces First Quarter 2026 Results
-
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
HealthStream Announces First Quarter 2026 Results
-
Innovative Industrial Properties Reports First Quarter 2026 Results
-
Samsara to Announce First Quarter Fiscal Year 2027 Financial Results on June 4, 2026
-
Viatris Announces Chief Financial Officer Transition
-
JELD-WEN Reports First Quarter 2026 Results and Updates Full Year Guidance
-
Tennant Company Board Authorizes Repurchase of Additional 2 Million Shares, Bringing Total Repurchase Capacity to Over 2.5 Million Shares
-
Versant to Present at the 2026 J.P. Morgan Global Technology, Media and Communications Conference
-
Agenus to Provide First Quarter 2026 Financial Report and Corporate Update
-
Bragg Gaming to Release First Quarter 2026 Results on May 14
-
H&R Block Announces Quarterly Cash Dividend
-
Kodiak Gas Services Announces First Quarter 2026 Earnings Release and Conference Call Timing
-
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
-
Anthem Blue Cross and Blue Shield Helps Georgia Small Businesses Lower Costs and Improve Health Outcomes
-
Amulet Capital Appoints Adam Grossman as Partner
-
AudioEye Announces Leadership Evolution: David Moradi Assumes the Role of Executive Chairman and Chief Product Officer, and Kelly Georgevich Becomes Chief Executive Officer
-
420 with CNW — GOP Congressmen Advance Legislation to Block Marijuana Rescheduling
-
REGIONAL HEALTH PROPERTIES ANNOUNCES APPOINTMENT OF MARLIE DAVIS AS CHIEF FINANCIAL OFFICER
-
Cabot Corporation Board Increases Dividend
-
Bakkt Schedules Conference Call to Discuss First Quarter 2026 Results
-
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
-
Microvast Schedules First Quarter Earnings Call
-
Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
-
TOP Financial Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Cellectis to Report First Quarter Financial Results on May 11, 2026
-
Teva to Present at the BofA Securities Health Care Conference

